Effect of Artemisia dracunculus Administration on Glycemic Control, Insulin Sensitivity, and Insulin Secretion in Patients with Impaired Glucose Tolerance

Journal of Medicinal Food

Volumn 19, Issue 5, 2016, Pages 481-485

  Méndez Del Villar, Miriam ^a   Puebla Pérez, Ana M ^a   Sánchez Peña, María J ^a   González Ortiz, Luis J ^a   Martínez Abundis, Esperanza ^a   González Ortiz, Manuel ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Glucose; Insulin; Prediabetes; Russian tarragon

Indexed keywords

ANTIDIABETIC AGENT; ARTEMISIA DRACUNCULUS EXTRACT; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN DERIVATIVE; MAGNESIUM OXIDE; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; HERBACEOUS AGENT; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTEMISIA DRACUNCULUS; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLYCEMIC CONTROL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MEAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; ARTEMISIA; BLOOD; BLOOD PRESSURE; CHEMISTRY; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED;

ADULT; ARTEMISIA; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL, HDL; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 84969222332     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2016.0005     Document Type: Article

References (31)

1. American Diabetes Association: Standards of medical care in diabetes-2016. Classification and diagnosis of diabetes. Diabetes Care 2016;39(Suppl 1):S13-S22.
2. Guerrero-Romero F, Rodrguez-Morán M, Pérez-Fuentes R, et al.: Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (MexDiab) Study. Metab Syndr Relat Disord 2008;6:15-23.
3. Kim HJ, Ahn HY, Kwak JH, et al.: The effects of chitosan oligosaccharide (GO2KA1) supplementation on glucose control in subjects with prediabetes. Food Funct 2014;5:2662-2669.
4. Cefalu WT, Ye J, Zuberi A, et al.: Botanicals and the metabolic syndrome. Am J Clin Nutr 2008;87:481S-487S.
5. Aglarova AM, Zilfikarov IN, Severtseva OV: Biological characteristics and useful properties of tarragon (Artemisia dracunculus L.) (Review). Pharm Chem J 2008;42:81-86.
6. Wang ZQ, Ribnicky D, Zhang XH, et al.: An extract of Artemisia dracunculus L enhances insulin receptor signaling and modulates gene expression in skeletal muscle in KK-Ay mice. J Nutr Biochem 2011;22:71-78.
7. Wang ZQ, Ribnicky D, Zhang XH, Raskin I, Yu Y, Cefalu WT: Bioactives of Artemisia dracunculus L enhance cellular insulin signaling in primary human skeletal muscle culture. Metab Clin Exp 2008;57:s58-s64.
8. Scherp P, Putluri N, LeBlanc GJ, et al.: Proteomic analysis reveals cellular pathways regulating carbohydrate metabolism that are modulated in primary human skeletal muscle culture due to treatment with bioactives from Artemisia dracunculus L. J Proteomics 2012;75:3199-3210.
9. Kheterpal I, Scherp P, Kellye L, et al.: Bioactives from Artemisia dracunculus L enhance insulin sensitivity via modulation of skeletal muscle protein phosphorylation. Nutrition 2014;30:S43-S51.
10. Kheterpal I, Coleman L, Ku G, Wang ZQ, Ribnicky D, Cefalu WT: Regulation of insulin action by an extract of Artemisia dracunculus L in primary human skeletal muscle culture: A proteomics approach. Phytother 2010;24:1278-1284.
11. Bloomer RJ, Canale R: Effect of an aqueous Russian tarragon extract on glucose tolerance in response to an oral dextrose load in non-diabetic men. Nutr Diet Suppl 2011;3:43-49.
12. Choi JY, Shin SK, Jeon SM, et al.: Dose-response study of sajabalssuk ethanol extract from Artemisia princeps Pampanini on blood glucose in subjects with impaired fasting glucose or mild type 2 diabetes. J Med Food 2011;14:101-107.
13. Eisenman SW, Pouley A, Struwe L, Raskin I, Ribnicky DM: Qualitative variation of anti-diabetic compounds in different tarragon (Artemisia dracunculus L) cytotypes. Fitoterapia 2011;82: 1062-1074.
14. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.
15. Stumvoll M, Mitrakou A, Pimienta W, et al.: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 2000;23:295-301.
16. Jeyaseelan L, Rao PSS: Methods of determining sample sizes in clinical trials. Indian J Pediatr 1989;26:115-121.
17. Li CL, Pan CY, Lu JM, et al.: Effect of metformin on patients with impaired glucose tolerance. Diabet Med 1999;16:477-481.
18. International Diabetes Federation. IDF Diabetes, 7 ed. Brussels, Belgium. International Diabetes Federation, 2015. http://www .diabetesatlas.org
19. Cefalu WT: Insulin resistance: Cellular and clinical concepts. Exp Biol Med 2001;226:13-26.
20. Govorko D, Logendra S, Wang Y, et al.: Polyphenolic compounds from Artemisia dracunculus L. inhibit PEPCK gene expression and gluconeogenesis in an H4IIE hepatoma cell line. Am J Physiol Endocrinol Metab 2007;293:E1503-E1510.
21. Aggarwal S, Shailendra G, Ribnicky DM, Burk D, Karki N, Wang MS: An extract of Artemisia dracunculus L. stimulates insulin secretion from b cells, activates AMPK and suppresses inflammation. J Ethnopharmacol 2015;170:98-105.
22. Ribnicky DM, Poulev A, Watford M, Cefalu WT, Rskin I: Antihyperglycemic activity of Tarralin-, an ethanolic extract of Artemisia dracunculus L. Phytomedicine 2006;13:550-557.
23. Cho JY, Park KH, Hwang DY, et al.: Antihypertensive effects of Artemisia scoparia waldst in spontaneously hypertensive rats and identification of angiotensin I converting enzyme inhibitors. Molecules 2015;20:19789-19804.
24. Gorzalczany S, Moscatelli V, Ferraro G: Artemisia copa aqueous extract as vasorelaxant and hypotensive agent. J Ethnopharmacol 2013;148:56-61.
25. Samyal ML, Kumar H, Khokra SL, Parashar B, Sahu RK, Ahmed Z: Evaluation of antidiabetic and antihyperlipidemic effects of Artemisia dracunculus extracts in streptozotocin-induced-diabetic rats. Pharmacologyonline 2011;2:1230-1237.
26. Jang WS, Kim YS, Seol IC: Antioxidant and lipid-lowering effects of Artemisia capillaris on a rat model of hyperlipidemia. J Korean Orient Med 2012;33:11-24.
27. Dinami NJ, Asgary A, Madani H, Naderi G, Mahzoni P: Hypocholesterolemic and antiatherosclerotic effect of Artemisia aucheri in hypercholesterolemic rabbits. Pak J Pharm Sci 2010; 23:321-325.
28. Weinoehrl S, Feistel B, Pischel I, Kopp B, Butterweck V: Comparative evaluation of two different Artemisia dracunculus L. cultivars for blood sugar lowering effects in rats. Phytother Res 2012;26:625-629.
29. Ribnicky DM, Poulev A, O'Neal J, Wnorowski G, Malek DE, Jäger R, Raskin I: Toxicological evaluation of the ethanolic extract of Artemisia dracunculus L for use as a dietary supplement and in functional foods. Food Chem Toxicol 2004;42:585-598.
30. González-Ortiz M, Martnez-Abundis E, Lifshitz A: Insulin sensitivity and sex steroid hormone levels during the menstrual cycle in healthy women with non-insulin dependent diabetic parents. Gynecol Obstet Invest 1998;46:187-190.
31. Sites CK, McKinney Shauna L: The metabolic syndrome: Impact on women and considerations for treatment. Menopausal Med 2008;6:S1-S7.